Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 13.93B | 13.00B | 12.88B | 11.92B | 12.70B | 11.60B |
Gross Profit | 4.33B | 4.00B | 4.09B | 3.70B | 4.09B | 3.47B |
EBITDA | 1.42B | 1.39B | 1.77B | 1.47B | 1.40B | 802.00M |
Net Income | 687.72M | 584.08M | 748.24M | 589.11M | 651.05M | 265.00M |
Balance Sheet | ||||||
Total Assets | 18.83B | 16.10B | 15.20B | 14.32B | 13.98B | 12.16B |
Cash, Cash Equivalents and Short-Term Investments | 1.34B | 1.63B | 1.63B | 1.35B | 1.53B | 1.50B |
Total Debt | 5.95B | 3.12B | 3.13B | 3.36B | 3.45B | 2.97B |
Total Liabilities | 10.28B | 7.81B | 7.85B | 7.83B | 8.37B | 7.29B |
Stockholders Equity | 8.55B | 8.28B | 7.35B | 6.50B | 5.62B | 4.86B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 126.19M | 573.95M | -7.55M | -349.35M | 437.00M |
Operating Cash Flow | 0.00 | 966.39M | 1.12B | 490.66M | 762.84M | 978.00M |
Investing Cash Flow | 0.00 | -838.81M | -643.92M | -496.46M | -1.13B | -599.00M |
Financing Cash Flow | 0.00 | -125.72M | -299.93M | -173.66M | 399.23M | -236.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥5.03B | 8.08 | 2.60% | 4.93% | -0.26% | ||
76 Outperform | ¥121.62B | 20.15 | 2.59% | 11.54% | -8.30% | ||
76 Outperform | ¥5.97B | 7.65 | 1.78% | 8.60% | 33.64% | ||
66 Neutral | ¥14.41B | 13.19 | 3.18% | 2.58% | -53.08% | ||
59 Neutral | £5.86B | 9.18 | -57.69% | 4.67% | 15.15% | -9.83% | |
56 Neutral | ¥10.53B | 118.63 | 3.94% | 6.83% | ― | ||
51 Neutral | ¥2.30B | 33.28 | 2.76% | 21.42% | -74.71% |